COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: from 24 hours after the start of mechanical ventilation for 7 days, every morning, patients were ventilated for 4 hours in APRV-LTV mode. Intervention 2: Control gr
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years No history of chronic respiratory diseases such as COPD Having a endotracheal tube and being connected to mechanical ventilation
Exclusion criteria
Exclusion criteria: The patient refuses to participating in the study Instability of the patient's vital signs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Heart rate. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Respiratory rate. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Static compliance rate. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;PaO2 / FiO2 ratio. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device.;Arterial blood oxygen saturation. Timepoint: Immediately before, 2 and 4 hours after the start of ventilation. Method of measurement: Vital Sign Monitoring Device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Abbasinis
Ghoum University of Medical Sciences
Outcome results
None listed